loadpatents
Patent applications and USPTO patent grants for Maw; Graham Nigel.The latest application filed is for "use of pde7 inhibitors for the treatment of neuropathic pain".
Patent | Date |
---|---|
Pyridine derivatives Grant 7,649,004 - Lane , et al. January 19, 2 | 2010-01-19 |
Use Of Pde7 Inhibitors For The Treatment Of Neuropathic Pain App 20090111837 - Cox; Peter ;   et al. | 2009-04-30 |
Pyridine Derivatives App 20080312235 - Lane; Charlotte Alice Louise ;   et al. | 2008-12-18 |
Therapeutic use of aryl amino acid derivatives Grant 7,053,122 - Maw , et al. May 30, 2 | 2006-05-30 |
Pharmaceutically active compounds App 20050107412 - Maw, Graham Nigel ;   et al. | 2005-05-19 |
Compounds for the treatment of female sexual dysfunction App 20050070499 - Maw, Graham Nigel ;   et al. | 2005-03-31 |
Azaquinazoline derivatives App 20050038047 - Edwards, Paul John ;   et al. | 2005-02-17 |
Compounds for the treatment of female sexual dysfunction App 20050020547 - Maw, Graham Nigel ;   et al. | 2005-01-27 |
Compounds for the treatment of female sexual dysfunction App 20040254153 - Maw, Graham Nigel ;   et al. | 2004-12-16 |
Pharmaceutically active compounds Grant 6,831,074 - Maw , et al. December 14, 2 | 2004-12-14 |
Pharmaceutical App 20040185094 - Maw, Graham Nigel ;   et al. | 2004-09-23 |
Therapeutic use of aryl amino acid derivatives App 20040138197 - Maw, Graham Nigel ;   et al. | 2004-07-15 |
Pharmaceutically active compounds Grant 6,756,373 - Allerton , et al. June 29, 2 | 2004-06-29 |
Compounds for the treatment of female sexual dysfunction Grant 6,734,186 - Maw , et al. May 11, 2 | 2004-05-11 |
Pharmaceutically active compounds App 20030013727 - Maw, Graham Nigel ;   et al. | 2003-01-16 |
Pharmaceutically active compounds Grant 6,503,908 - Maw January 7, 2 | 2003-01-07 |
Pharmaceutically active compounds App 20030004173 - Maw, Graham Nigel ;   et al. | 2003-01-02 |
Pharmaceutically active compounds App 20020193388 - Maw, Graham Nigel ;   et al. | 2002-12-19 |
Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase App 20020052370 - Barber, Christopher Gordon ;   et al. | 2002-05-02 |
Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction Grant 6,333,330 - Bunnage , et al. December 25, 2 | 2001-12-25 |
Compounds as delta opioid agonists Grant 6,200,978 - Maw , et al. March 13, 2 | 2001-03-13 |
Indoles which have steroid 5-.alpha. reductase inhibitory activity Grant 5,767,139 - Maw , et al. June 16, 1 | 1998-06-16 |
Indole derivatives as steroid 5.alpha.-reductase inhibitors Grant 5,696,146 - Blagg , et al. December 9, 1 | 1997-12-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.